Toggle navigation
Home
Search
Services
Blog
Contact
About
Cloning and Characterization of the LR3 Receptor
Hembrough, Todd A.
American National Red Cross, Washington, DC, United States
Search 3 grants from Todd Hembrough
Search grants from American National Red Cross
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Noninvasive Low-cost Biomarkers for Preclinical Diagnosis and Longitudinal Tracking of Alzheimer's Disease Using Sleep and Resting State EEG
Safety & Effect of Vpa 985 in Treatment of Patients W/ Hyponatremia
Oxalins and Cell Proliferation and Regulation
Anticoagulant Therapy in Older Patients
Electronic Structure of Ferric Porphyrins
Recently added grants:
Development of next generation 2HG and metabolic MR imaging for precision oncology of mutant IDH and wildtype glioma patients
Molecular basis of activation of the orphan nuclear receptor Nurr1
Elucidating the role of NK cells in Lewy body diseases
Optical analogs to MRI contrast agents for surgical guidance of brain tumor resection
Representation and utilization of sensory uncertainty in the primate visual system
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
5F32HL009910-03
Application #
6125684
Study Section
Medical Biochemistry Study Section (MEDB)
Project Start
1999-12-01
Project End
Budget Start
1999-12-01
Budget End
2000-02-28
Support Year
3
Fiscal Year
2000
Total Cost
$21,616
Indirect Cost
Institution
Name
American National Red Cross
Department
Type
DUNS #
003255213
City
Washington
State
DC
Country
United States
Zip Code
20006
Related projects
NIH 2000
F32 HL
Cloning and Characterization of the LR3 Receptor
Hembrough, Todd A. / American National Red Cross
$21,616
NIH 1999
F32 HL
Cloning and Characterization of the LR3 Receptor
Hembrough, Todd A. / American National Red Cross
NIH 1998
F32 HL
Cloning and Characterization of the LR3 Receptor
Hembrough, Todd A. / American National Red Cross
Publications
Hembrough, T A; Ruiz, J F; Papathanassiu, A E et al.
(2001)
Tissue factor pathway inhibitor inhibits endothelial cell proliferation via association with the very low density lipoprotein receptor.
J Biol Chem 276:12241-8
Comments
Be the first to comment on Todd Hembrough's grant